No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
US OptionsDetailed Quotes
INMD240719C19000
- 0.07
- -0.06-46.15%
15min DelayClose Jul 15 15:59 ET
0.24High0.05Low
0.24Open0.13Pre Close28 Volume1.01K Open Interest19.00Strike Price197.00Turnover54.92%IV6.95%PremiumJul 19, 2024Expiry Date0.00Intrinsic Value100Multiplier4DDays to Expiry0.07Extrinsic Value100Contract SizeAmericanOptions Type0.1450Delta0.2207Gamma237.73Leverage Ratio-0.0287Theta0.0003Rho34.47Eff Leverage0.0043Vega
Intraday
- 5D
- Daily
News
Barclays Lowers Price Target on InMode to $29 From $33, Maintains Overweight Rating
InMode (INMD) has an average outperform rating and price target range of $16 to $29, according to analysts polled by Capital IQ.Price: 17.78, Change: -0.10, Percent Change: -0.53
InMode Price Target Cut to $29.00/Share From $33.00 by Barclays
InMode Price Target Cut to $29.00/Share From $33.00 by
InMode Is Maintained at Overweight by Barclays
InMode Is Maintained at Overweight by
Express News | Inmode : Barclays Cuts Target Price to $29 From $33
Barclays Maintains InMode(INMD.US) With Buy Rating, Maintains Target Price $29
Barclays analyst Matt Miksic maintains $InMode(INMD.US)$ with a buy rating, and maintains the target price at $29.According to TipRanks data, the analyst has a success rate of 61.1% and a total
Barclays Maintains InMode(INMD.US) With Buy Rating, Cuts Target Price to $29
Barclays analyst Matt Miksic maintains $InMode(INMD.US)$ with a buy rating, and adjusts the target price from $33 to $29.According to TipRanks data, the analyst has a success rate of 61.1% and a
Comments
Needham suggests InMode, a key player in body contouring, could gain from market trends. The company also promotes the Morpheus8 skin-tightening system. These findings mirror sales trends reported by Botox producer Allergan, predicting an 8% YoY global sales growth for cosmetic use by 2024.
Survey Finds GLP-1 Users More Inclined to Get Aesthetic Procedures 1
- Reached previously shared possible support at 28
- RSI severely oversold (previous only time was early 2022)
- Pre-earnings coming up next week
- 30mins chart finally saw a good double bottom formed
- In line with overall market firming up
Time to sell puts.
@BeBlessed @Deposit @icezzz @Jamesbond86 @KC Yap @克里斯托弗陈 @Mohamad Ghadafi @meruson @奇宝 @SiokJS @Tadamaen @圖畫裡龍不吟萀不嘯 @10-10 @71623800 @102987758 @102402910 @102390299 @101815910 @101688622
...
- RSI severely oversold (previous only time was early 2022)
- Pre-earnings coming up next week
- 30mins chart finally saw a good double bottom formed
- In line with overall market firming up
Time to sell puts.
@BeBlessed @Deposit @icezzz @Jamesbond86 @KC Yap @克里斯托弗陈 @Mohamad Ghadafi @meruson @奇宝 @SiokJS @Tadamaen @圖畫裡龍不吟萀不嘯 @10-10 @71623800 @102987758 @102402910 @102390299 @101815910 @101688622
...
10
$InMode(INMD.US$ just companies nail it on earnings, cannot wait to see what the new price targets and upgrades. This company will continue to take away from customer from doing liposuction and Ozempic face customers. go thier thier instagram and there work is amazing!!!
3
Past few sharing of anaylsis on INMD were spot on!
- Pre-earnings guidance on 12 July ==> checked!
- Target of 45 ==> checked!
- Charted the rally since higher low on 2nd June ==> checked!
That's why observe, react, don't predict! Let the price action guide you!
Significance of Wednesday
- 40 has been a resistance past few run up
- Wed, bulls tactically gapped up over 40 at market start! ==> triggered so many stop losse...
- Pre-earnings guidance on 12 July ==> checked!
- Target of 45 ==> checked!
- Charted the rally since higher low on 2nd June ==> checked!
That's why observe, react, don't predict! Let the price action guide you!
Significance of Wednesday
- 40 has been a resistance past few run up
- Wed, bulls tactically gapped up over 40 at market start! ==> triggered so many stop losse...
6
- Have been charting the rise towards earnings pre-guidance which INMD tends to do 2 weeks prior to actual earnings. And we are in the usual run up to that day.
- A positive reaction will see a jump up of good magnitude
- Bull flag had been forming well since the higher low in early June
- MA5/MA20 are all up and there is upside to go in this rise
- Fib extension of bull flag points to Fib 1.0 of 39 (broken) and next i...
- A positive reaction will see a jump up of good magnitude
- Bull flag had been forming well since the higher low in early June
- MA5/MA20 are all up and there is upside to go in this rise
- Fib extension of bull flag points to Fib 1.0 of 39 (broken) and next i...
7
Read more